Anu K Solanki1,2,3, Ferdinand V Lali4, Hélène Autefage1,2,3, Shweta Agarwal1,2,3, Amy Nommeots-Nomm1, Anthony D Metcalfe5, Molly M Stevens6,7, Julian R Jones8. 1. Department of Materials, Imperial College London, South Kensington, London, SW7 2AZ, UK. 2. Institute of Biomedical Engineering, Imperial College London, South Kensington, London, SW7 2AZ, UK. 3. Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK. 4. The Griffin Institute, Northwick Park & St Mark's Hospitals Campus, Watford Road, Harrow, HA1 3UJ, UK. 5. Healthcare Technologies Institute, School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. 6. Department of Materials, Imperial College London, South Kensington, London, SW7 2AZ, UK. m.stevens@imperial.ac.uk. 7. Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK. m.stevens@imperial.ac.uk. 8. Department of Materials, Imperial College London, South Kensington, London, SW7 2AZ, UK. julian.r.jones@imperial.ac.uk.
Abstract
BACKGROUND: Bioactive glasses are traditionally associated with bonding to bone through a hydroxycarbonate apatite (HCA) surface layer but the release of active ions is more important for bone regeneration. They are now being used to deliver ions for soft tissue applications, particularly wound healing. Cobalt is known to simulate hypoxia and provoke angiogenesis. The aim here was to develop new bioactive glass compositions designed to be scaffold materials to locally deliver pro-angiogenic cobalt ions, at a controlled rate, without forming an HCA layer, for wound healing applications. METHODS: New melt-derived bioactive glass compositions were designed that had the same network connectivity (mean number of bridging covalent bonds between silica tetrahedra), and therefore similar biodegradation rate, as the original 45S5 Bioglass. The amount of magnesium and cobalt in the glass was varied, with the aim of reducing or removing calcium and phosphate from the compositions. Electrospun poly(ε-caprolactone)/bioactive glass composites were also produced. Glasses were tested for ion release in dissolution studies and their influence on Hypoxia-Inducible Factor 1-alpha (HIF-1α) and expression of Vascular Endothelial Growth Factor (VEGF) from fibroblast cells was investigated. RESULTS: Dissolution tests showed the silica rich layer differed depending on the amount of MgO in the glass, which influenced the delivery of cobalt. The electrospun composites delivered a more sustained ion release relative to glass particles alone. Exposing fibroblasts to conditioned media from these composites did not cause a detrimental effect on metabolic activity but glasses containing cobalt did stabilise HIF-1α and provoked a significantly higher expression of VEGF (not seen in Co-free controls). CONCLUSIONS: The composite fibres containing new bioactive glass compositions delivered cobalt ions at a sustained rate, which could be mediated by the magnesium content of the glass. The dissolution products stabilised HIF-1α and provoked a significantly higher expression of VEGF, suggesting the composites activated the HIF pathway to stimulate angiogenesis.
BACKGROUND: Bioactive glasses are traditionally associated with bonding to bone through a hydroxycarbonate apatite (HCA) surface layer but the release of active ions is more important for bone regeneration. They are now being used to deliver ions for soft tissue applications, particularly wound healing. Cobalt is known to simulate hypoxia and provoke angiogenesis. The aim here was to develop new bioactive glass compositions designed to be scaffold materials to locally deliver pro-angiogenic cobalt ions, at a controlled rate, without forming an HCA layer, for wound healing applications. METHODS: New melt-derived bioactive glass compositions were designed that had the same network connectivity (mean number of bridging covalent bonds between silica tetrahedra), and therefore similar biodegradation rate, as the original 45S5 Bioglass. The amount of magnesium and cobalt in the glass was varied, with the aim of reducing or removing calcium and phosphate from the compositions. Electrospun poly(ε-caprolactone)/bioactive glass composites were also produced. Glasses were tested for ion release in dissolution studies and their influence on Hypoxia-Inducible Factor 1-alpha (HIF-1α) and expression of Vascular Endothelial Growth Factor (VEGF) from fibroblast cells was investigated. RESULTS: Dissolution tests showed the silica rich layer differed depending on the amount of MgO in the glass, which influenced the delivery of cobalt. The electrospun composites delivered a more sustained ion release relative to glass particles alone. Exposing fibroblasts to conditioned media from these composites did not cause a detrimental effect on metabolic activity but glasses containing cobalt did stabilise HIF-1α and provoked a significantly higher expression of VEGF (not seen in Co-free controls). CONCLUSIONS: The composite fibres containing new bioactive glass compositions delivered cobalt ions at a sustained rate, which could be mediated by the magnesium content of the glass. The dissolution products stabilised HIF-1α and provoked a significantly higher expression of VEGF, suggesting the composites activated the HIF pathway to stimulate angiogenesis.
Authors: Xiufang Li; Yan Liu; Jian Zhang; Renchuan You; Jing Qu; Mingzhong Li Journal: Mater Sci Eng C Mater Biol Appl Date: 2016-11-24 Impact factor: 7.328
Authors: Mira Milas; Ruth L Bush; Peter Lin; Kathy Brown; Greg Mackay; Alan Lumsden; Collin Weber; Thomas F Dodson Journal: J Vasc Surg Date: 2003-03 Impact factor: 4.268
Authors: Alexander Hoppe; Bojan Jokic; Djordje Janackovic; Tobias Fey; Peter Greil; Stefan Romeis; Jochen Schmidt; Wolfgang Peukert; Jonathan Lao; Edouard Jallot; Aldo R Boccaccini Journal: ACS Appl Mater Interfaces Date: 2014-02-10 Impact factor: 9.229
Authors: Jiongyu Ren; Keith A Blackwood; Amir Doustgani; Patrina P Poh; Roland Steck; Molly M Stevens; Maria A Woodruff Journal: J Biomed Mater Res A Date: 2013-10-17 Impact factor: 4.396